David Kinsley - Concepedia

Author

David Kinsley

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

David J Kinsley, David J. Kinsley, David Kinsley

Publications

729

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Boehringer Ingelheim (United States)University of Pittsburgh La Roche College AGCO (United Kingdom)

About

David Kinsley is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, autoimmunity, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	404
2	Cell Biology	4	4	322
3	Cellular Physiology	2	2	79
4	Allergy	1	1	82
5	Biochemistry	1	1	12

David Kinsley

Publications

723

Citations

H-Index

Page 1

	Year	Citations
Ectopic Expression of the Murine Chemokines CCL21a and CCL21b Induces the Formation of Lymph Node-Like Structures in Pancreas, But Not Skin, of Transgenic Mice Shucheng Chen, Galya Vassileva, David Kinsley, The Journal of Immunology Ccl21 ProteinsImmunologyImmune RegulationPathologyCc Chemokine Ccl21	2002	201
Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice Michaela C. Stanton, Shu‐Cheng Chen, James V. Jackson, Journal of Inflammation	2011	134
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection Chung-Her Jenh, Mary Ann Cox, Long Cui, BMC Immunology	2012	82
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection Chung‐Her Jenh, Mary Ann Cox, Long Cui, BMC Immunology ImmunologyImmunologic MechanismImmunotherapyInflammationCxcr3 Receptor	2012	82
MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy Xiaohai Wang, Wenping Li, Jacob Marcus, Journal of Pharmacology and Experimental Therapeutics	2020	73
Disruption of Neutrophil Migration in a Conditional Transgenic Model: Evidence for CXCR2 Desensitization In Vivo Maria Wiekowski, Shu‐Cheng Chen, Petronio Zalamea, The Journal of Immunology Innate Immune SystemImmunologyPathologyConditional Transgenic ModelCellular Physiology	2001	67
Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions Shu‐Cheng Chen, Marjan de Groot, David Kinsley, Archives of Dermatological Research InflammationPlasmacytoid Dendritic CellsChemokine Receptor Cxcr3MedicineImmunology	2009	42
Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336 Waldemar Gonsiorek, David Hesk, Shu‐Cheng Chen, Journal of Biological Chemistry	2006	30
Characterization of a murine keyhole limpet hemocyanin (KLH)-delayed-type hypersensitivity (DTH) model: Role for p38 kinase Laura Engstrom, Maria Pinzon-Ortiz, Ying Li, International Immunopharmacology Signal TransductionSignaling PathwayBiochemistryG Protein-coupled ReceptorP38 Kinase	2009	12

Page 1